Here’s what we’ve learned so far.
Now that startups can deliver at-home microbiome testing kits straight to your door, and with do-it-yourself fecal transplants a topic of polite conversation, we can safely say that consumer interest in the vast community of organisms that inhabit our bodies-that is to say, the microbiome-has hit mainstream status.
But rank-and-file civilians are merely catching up with the scientific community, which has been intrigued by the identity-and the implications-of the bacteria, fungi, and even viruses that make us…well, us since long before the National Institutes of Health launched the Human Microbiome Project in 2008.
And all along, research findings have had no trouble keeping investigators’ attention rapt-or keeping the dietary supplement space licking its chops at the prospect of products that can harness the microbiome’s benefits. As Joseph Petrosino, PhD, professor, Baylor College of Medicine (Houston, TX), notes, “Excitement exists because the microbiome is being shown to impact health and disease broadly, and may be readily modified to treat a specific disease state without the side effects attributed to other drug treatments.”
But it’s a long way from here to there, with plenty still to learn. Nonetheless, experts agree: No matter how long it takes to put the puzzle together, the pieces are already falling into place.
CLICK ON IMAGES TO VIEW SLIDESHOW
Photo © Shutterstock.com/vrx
Prinova acquires Aplinova to further increase its footprint in Latin America
April 7th 2025Prinova has recently announced the acquisition of Brazilian ingredients distributor Aplinova, which is a provider of specialty ingredients for a range of market segments that include food, beverage, supplements, and personal care.